Atlas Trials

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Clinical trial NCT00915525 · COMPLETED

Trial details

NCT number
NCT00915525
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Overactive BladderUrinary Incontinence
Start date
2010-02-01
Primary completion
2014-08-05
Enrollment
829

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.